Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Use of the Impella ECP in Patients Undergoing an Elective or Urgent High-Risk Percutaneous Coronary Intervention Impella ECP Continued Access Protocol

NCT05334784 is registered in ClinicalTrials.gov with Abiomed Inc. as lead sponsor.

NCT NCT05334784
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05334784 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Use of the Impella ECP in Patients Undergoing an Elective or Urgent High-Risk Percutaneous Coronary Intervention Impella ECP Continued Access Protocol
Lead sponsor
Abiomed Inc.
Phase
Not applicable
Overall status
Enrolling by invitation
Start date
December 20, 2022
Completion date
December 31, 2026
Enrollment
856 (estimated)
Sites
32

Conditions

As the registry lists them; a condition with its own page is linked.

high-risk percutaneous coronary intervention